The selectivity of anticancer drugs in targeting the tumour tissue presents a major problem in
cancer treatment. In this article we review a new generation of smart liposomal nanocarriers …

Previous studies in our laboratory demonstrated that high-performance liquid
chromatography (HPLC) analysis of ground corncob bedding extracts characterized two …

Tumor growth, vascularization, invasion, and metastasis require activation and/or
proliferation of specific host cells, and, perhaps, deactivation and/or suppression of others …

Objective To find new biomarkers for early diagnosis of breast cancer. Results 847 lipid
species were identified from 78 plasma samples (37 breast cancer samples and 41 healthy …

Arachidonic acid (AA) is a phospholipase A2 metabolite that has been reported to mediate a
plethora of cellular mechanisms involved in healthy and pathological states such as platelet …

Sensitive and specific biomarkers for pancreatic cancer are currently unavailable. The high
mortality associated with adenocarcinoma of the pancreatic epithelium justifies the broadest …

It is well-known that the plasma level of group IIA phospholipase A 2 (sPLA 2-IIA) is
increased in patients with malignant diseases, but whether the up-regulated enzyme …

Abstract Phospholipases A2 (PLA2s) overexpression is closely associated with the
malignant potential of breast cancers. Here, we showed for the first the antitumoral effects of …

Identification of new biomarkers for breast cancer remains critical in order to enhance early
detection of the disease and improve its prognosis. Towards this end, we performed an …

Abstract BACKGROUND Group II phospholipase A2 (PLA2) is a lipolytic enzyme suggested
to play a role in inflammation and antibacterial defence. In seminal fluid, the concentration of …